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Abstract
Mesenchymal stem cells (MSCs) are a population of stromal cells found
traditionally in the bone marrow and adipose tissues. They can also be found in
other tissues including fallopian tube, core blood, peripheral blood, fetal liver, and
lungs. Mesenchymal stem cells have profound effects in regenerative engineering,
tissue repair and drug discovery owing to the excellent properties such as
proliferation, self-renewal, and multipotency generating multiple cell types
including adipocytes, osteocytes, cardiomyocytes (CMs), pericytes (PCs), and
chondrocytes. MSCs are used as immunomodulators in generating progenitor
cells to be used for transplantation, creating engineered organs, and preventing
graft vs. host disease (GVHD). MSCs can differentiate into vascular lineages such
as endothelial and smooth muscle cells (SMCs) which have a necessity for creating
personalized cell therapies such that SMCs are considered a critical component of
tissue-engineered vascular grafts. However, the use of mesenchymal stem cells is
restricted by specific factors including their scarceness in tissues, donor age,
culture media, origin of the cells, and gene expression profiles. For example,
although adipose-derived and bone marrow-derived mesenchymal stem cells
share many biological characteristics, they have some differences that affect their
differentiation density, proliferation density, gene expression that results in
different osteogenic and chondrogenic differentiation capacity. Consequently,
these differences should be taken into consideration when planning stem cellbased therapy using MSCs. The goal of this research was to determine the effect
of cell line-specific differences, specifically the donor origin, on the differentiation
adipose tissue-derived mesenchymal stem cells (Ad-MSCs) towards SMCs. This
goal was achieved using Ad-MSCs from a 30-year old Hispanic female (ATCC1 cell

line) as staining control, then comparing the expression of myosin heavy chain 11
(MYH11) between Ad-MSCs taken from a 24-year old Caucasian female (82726
cell line) and a 29-year old native American female (99375 cell line) after 4-day
differentiation into SMCs using flow cytometer and FlowJo® software to analyze
the data. The results proved that the donor’s origin influences the differentiation
of Ad-MSCs towards SMCs.

Introduction
MSCs are primitive multipotent progenitors present traditionally in the bone
marrow and adipose tissues [1]. They can exist in peripheral blood, lungs, dermal
tissues, intervertebral disc, amniotic fluid, human placenta, and cord blood [2]. In
Vitro, MSCs are plastic-adherent fibroblast spindle-like shaped cells [3]. MSCs
have promising future and tremendous potential in regenerative medicine and
tissue engineering thanks to their capability of proliferating into daughter cells
that have the same gene expression, phenotype, and stemness. MSCs can also
differentiate into osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes
(muscle cells), adipocytes (fat cells), endothelial and smooth muscle cells (SMCs)
[4].

The reason why we are concerned about MSC-derived SMCs is because they
proved their proliferative and impressive differentiation potential. For example,
they could migrate into decellularized mouse aorta resulting in the formation of

smooth muscle layer of vascular grafts and that demonstrated they are a critical
component in generating vascular grafts. They also displayed contractility in vitro
and supported the formation of the vascular structure in the Matrigel plug assay
in vivo [5]. Although there are surgical mainstays for peripheral vascular diseases
such as synthetic grafts made of polytetrafluoroethylene (Dacron) or Teflon or
autologous grafts from mammary blood vessels, these synthetic grafts are not
compatible and can cause thrombosis and intimal hyperplasia. Consequently,
instead of using such synthetic grafts, tissue engineering approaches like culturing
SMCs on synthetic materials or natural material such as fibrin or silk to generate
tubular conduits can fulfill this clinical need. However, one important factor that
affects the success of these vascular grafts and their efficiency is the source of
SMCs and the donor age [6].

In general, differentiation of MSCs in vitro is affected by many external factors
and the culture conditions that should be controlled to direct the fate and the
function of the resulted cells in clinical situations [7]. Some of these factors are
the cell source, donor age, density of used cells, passage number, plastic surface
quality, supplementary factors, oxygen concentration, and mechano-/electrostimuli [8]. Geometric shape cues also affect the fate of MSCs by controlling the
mechanochemical signals and paracrine/autocrine factors. When cells are
exposed to a mixture of lineage cues, geometric shapes that enhance the
contractility result in osteogenesis because these shapes increase the myosin that
enhances the osteogenesis pathways. On the other side, geometric shapes that
promote low contractility direct cells into adipocyte lineage. It was proved that

cells differentiate in response to shape cues in a way consistent with the native
geometry of the cell lineage. For example, rounded cells with low stress enhance
differentiation towards fat cells, and contractile pointed cells promote
differentiation towards bone cells [9]. An example of the differences depending
on the origin of the cells is that adipose and bone marrow-derived mesenchymal
stem cells show differences in their immunophenotype, differentiation potential,
immunomodulatory, transcriptome, proteome, and gene marker expression [10].
For example, adipose tissue-derived mesenchymal stem cells (Ad-MSCs) have
higher expression of CD49d and lower expression of Stro-1 compared to bone
marrow mesenchymal stem cells (BM-MSCs). In general, Ad-MSCs have higher
proliferation, adipogenic capacity, more lipid vesicle formation, and higher
expression of adipogenesis-related genes [11]. Ad-MSCs are also easier to be
isolated, safer and give larger amounts compared to BM-MSCs. On the other
hand, BM-MSCs have higher osteogenic and chondrogenic capacity compared to
Ad-MSCs [10]. Consequently, BM-MSCs have higher calcium deposition and higher
expression of osteogenesis and chondrogenesis-related genes [11]. Most
importantly, despite the minor differences between these MSC populations, they
both work effectively in clinical applications [10]. All these differences should be
takes into consideration when using MSCs to generate other cell lineages to have
the targeted function with the highest efficiency.

In this study, fluorescence-activated cell sorting (FACS) was used to sort
heterogeneous mixtures of biological cells, one cell at a time, based on the
fluorescent characteristics of each cell. FACS is based on the phenotype

differences between cells since each cell type has certain phenotype, certain
extracellular and intracellular molecules, and different gene markers [12].
Typically, the cells in the suspension are tagged with fluorescent antibodies.
These tags allow cells to be identified and isolated into a liquid medium for
further analysis using FlowJo® software. When cell particles pass through a laser
beam, they are monitored and are given positive or negative charge based on the
presence or the absence of the fluorescently tagged antibody, respectively. Then
these particles are separated based on their charge depending on their electric
field into collection tubes with respect to the primary antibodies tagged with the
fluorescent antibodies [13]. In this paper, cells were fixed, blocked, mixed with
primary and secondary antibodies that attached to the extracellular gene
markers. Then cells were permeabilized to provide access to intracellular
antibodies, followed by mixing the cells with another primary and secondary
antibodies that attached to the intracellular gene markers. The secondary
antibody is a fluorescent molecule that attaches to the primary antibody specific
for a particular cell surface protein after itself being attached to the extracellular
or the intracellular gene markers. Figure (1) is a representation of FACS as it
shows a population of mixed cells sorted into a negative and a positive sample
containing cells of interest based on of the florescence dye [14]. Figure (1) also
shows forward (FSC) and side scattering (SSC) gating that are commonly used
when cells are distinguished based on their size and complexity, respectively,
based on light reflection [14]. This gating is always used when studying cells of
different sizes and complexity such as red blood cells and white blood cells but in
this study the focus was on the differentiation of MSCs only, so we used the
fluorophore expression.

The goal of this study was to examine the effect of cell line-specific differences,
especially the donor origin as a biological variable in guiding differentiation of AdMSCs towards SMCs. This goal was achieved using three different cell lines from
different donors: a 30-year old Hispanic female (ATCC1, which is the staining
control), a 24-year old Caucasian female (82726) and a 29-year old native
American female (99375). Each cell line was seeded in culture media and plateletderived growth factor mixed with transforming growth factor beta1
(PDGF+TGFβ1), the differentiation media, for 4 days. Then Fluorescence-Activated
Cell Sorting (FACS) was used to detect intracellular and the extracellular cell
markers and data were analyzed using FlowJo® software.

Figure (1) represents fluorescence‐activated cell sorting (FACS). FSC is forward
scattering & SSC is side scattering. Obtained from https://www.bosterbio.com/protocoland-troubleshooting/flow-cytometry-principle#flow_principle [14].

Methods
Thawing and Passaging Cell Lines
Thawing and passaging is done in the laminar flow and before using the hood it
should be sterilized by sparing 70% ethanol. Also, everything that enters the
hood should be sprayed first to avoid contamination. The three cell lines that
were used are from a 30-year old female Hispanic (ATCC1), a 24-year old
Caucasian female (82726) and a 29-year old native American female (99375). The
passage number of these cell lines was between 4-15 and they were proliferated
in the lab for almost a year. Before getting the cell ampoules out of the liquid
nitrogen, the culture media (low-glucose DMEM medium (Gibco, MA),
supplemented with 10% v/v MSC qualified FBS (Gibco, MA) and 1% v/v AB/AM
(Gibco, MA)) was warmed in the water bath for at least 15 minutes. Three 15𝑚𝑙
centrifuge tubes were prepared by labeling each one with the cell line name and
adding 8 ml of pre-warmed culture media in each tube. The cell ampoules were
taken out of the liquid nitrogen storage wearing the personal protective
equipment. Then these ampoules were rubbed gently for 1 minute and placed in
the water bath for 1 minute. Thawing should be done rapidly to minimize any
damage to the cell membranes. To avoid contamination, the ampoules were not
immersed completely in the water bath, only the bottom part was immersed. The
cell solution from each vial was added in its corresponding centrifuge tube. To
make sure that there were no cells left on the walls of the ampoules, 1𝑚𝑙 of the
culture media was added to each ampoules and pipetted two times then the
solution was added to its corresponding tube. The centrifuge tubes were then
centrifuged at 1200 𝑅𝑃𝑀 at 40℃ for 3 𝑚𝑖𝑛𝑢𝑡𝑒𝑠. During the centrifugation, three

T-175 flasks were prepared by adding 8 𝑚𝑙 of culture media and labeling each
flask with the cell line name, passage number, and the date. When centrifugation
was done, the supernatant was discarded carefully without disrupting the pellet
leaving 1 𝑚𝑙 of the supernatant in each tube. Then the bullet was disrupted in
that 1𝑚𝑙 by pipetting almost 10 times carefully to avoid having air bubbles. After
the bullet was completely dissolved in the 1𝑚𝑙 solution, each cell solution was
added to its corresponding flask. After that, rock each flask back and forth several
times to make sure that the cells would evenly grow without forming any clusters.
Finally, the flasks were checked under the microscope to make sure that the
media was spread evenly and then were placed in the incubator.

To proliferate cells, passaging was done once every two days over a year. Trypsin
EDTA which is the dissociation reagent, trypsin neutralizing solution (TNS) that
neutralizes the trypsin EDTA, culture media, and phosphate buffered saline (PBS)
that lacks 𝐶𝑎2+ /𝑀𝑔2+ and is used to wash the cells from their wastes were put in
the water bath for at least 15 minutes before being used. Before starting
passaging, the flasks were checked under the microscope to make sure there was
no contamination or deterioration. Under microscope, alive cells were kept
adherent to the flask bottom while dead cells would be floating in the culture
media. Spent medium was removed using sterile pipette and the cells were
washed twice using 10 𝑚𝑙 of the pre-warmed PBS for each flask. Each time after
adding the PBS, flasks were shaken in the four directions to get complete
coverage of the cell layer. Followed by aspirating the PBS and adding 10 𝑚𝑙 of
pre-warmed trypsin EDTA to each flask then the flasks were shaken again to

ensure the coverage of all cells with the dissociation reagent. The flasks were
incubated for 5 minutes. In the meantime, prepare three 15𝑚𝑙 centrifuge tubes
by labeling them with the names of the cell lines and prepare four T-175 flasks,
two for each cell line, by labeling them with the date, the name of the cell line,
the passage number, and by adding 14 𝑚𝑙 of culture media. After the 5 minutes
of incubation, the flasks were tapped from the four directions to expedite cell
detachment then checked under microscope ensuring that the cells were floating
as single circles or clusters. This process should not take long as the more the cells
left in the trypsin EDTA, the more damage will happen to the cell membranes and
cells may die. Thus, equal amount of TNS was added to each flask ending with
ratio of 1:1 of trypsin EDTA: TNS. Then each cell solution was transferred to the
pre-prepared centrifuge tubes and centrifuged at 1200 𝑅𝑃𝑀 at 40℃ for
3 𝑚𝑖𝑛𝑢𝑡𝑒𝑠 to remove any residual dissociation reagent. When centrifugation
finished, the supernatant was discarded using a pipette without disrupting the
pellet leaving 2 𝑚𝑙 of the solution in each centrifuge tube to resuspend the pellet
by pipetting carefully without forming air bubbles in order not to waste cells and
to ensure homogenous solution for single cells. Then 1 𝑚𝑙 from each centrifuge
tube was pipetted into its corresponding pre-prepared flask. Finally, rock each
flask back and forth several times to make sure that the cells covered the flask
and would grow evenly, not in clusters, and incubate them for another two days.

Coating, Counting Cells Using Hemocytometer and Differentiating the cells
After 4 weeks of culturing and passaging the cells and before starting counting the
cells, six T-25 flasks were coated to be prepared for differentiation. This was done
my mixing 3.43 𝑚𝑙 of Hanks' Balanced Salt Solution (HBSS) with 0.34𝜇𝑙 of
fibronectin then 0.86 𝑚𝑙 of this solution was added for 1 ℎ𝑜𝑢𝑟 into each opened
T-25 flask in the laminar flow cabinet. HBSS is used as a transport media to
preserve cells and minimize bacterial overgrowth [15] and fibronectin is
important for cell differentiation, adhesion, and growth [16]. In the meanwhile,
the differentiation media was prepared by mixing Platelet-derived growth factor
of concentration 10 𝑛𝑔/𝑚𝑙 and transforming growth factor β1 of concentration
2.5 𝑛𝑔/𝑚𝑙 (PDGF+TGFβ1) .
To count cells, the passaging steps were followed till the step of resuspending the
cells in the 2 𝑚𝑙 of the solution. To achieve single cell suspension and accurate
cell count, the cell solution in each centrifuge tube was repeatedly pipetted
without forming any air bubbles. After disrupting the cell pellet, small portion of
the cell solution (10 𝜇𝑙) was taken from each centrifuge tube and put into two
microcentrifuge tubes after labeling them with the cell name. An equal amount of
trypan blue dye was added to each microcentrifuge tube (10 𝜇𝑙) so the cell
solution: trypan blue dye was 1:1. The trypan blue is used to determine the ratio
of alive to dead cells by staining dead cells blue while alive cells with intact cell
membrane are kept white or colorless with a small dot inside which is the
nucleus. In each microcentrifuge tube, the solution was mixed well by pipetting 5
times without forming air bubbles and allowed to stand for 3-5 minutes. For then,
the cover slip and the hemocytometer were cleaned using 70% ethanol and
kimwipes. Then 10 𝜇𝑙 of blue-cell suspension from each microcentrifuge tube

were transferred to one of the two chambers of the hemocytometer without
overfilling or underfilling the chamber. Then cells were viewed under microscope
at 100 × magnification and the alive cells in the lateral four squares were
counted. The following equation was used to count cells:
𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑐𝑒𝑙𝑙𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑓𝑜𝑢𝑟 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 × 2 × 104
The 2 represents the ratio of the cell solution: trypan blue and the 104 is the area
of the four squares.
Number of cells of ATCC1: 187500 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙
Number of cells of 82726: 280000 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙
Number of cells of 99375: 560000 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙
There should be 2000 𝑐𝑒𝑙𝑙𝑠/𝑐𝑚2
Then, there should be

2000 𝑐𝑒𝑙𝑙𝑠 ×25𝑐𝑚2
𝑐𝑚2

= 50000 𝑐𝑒𝑙𝑙𝑠 in each T-25 flask.

Two flasks for each cell line were used: one that had culture media (low-glucose
DMEM medium (Gibco, MA), supplemented with 10% v/v MSC qualified FBS
(Gibco, MA) and 1% v/v AB/AM (Gibco, MA)) and the other one had PDGF+TGFβ1,
the differentiation media. After two days the culture media was changed
completely, and half of the differentiation was changed (semi-batch culture).

Intracellular and Extracellular marker staining of cells
To dissociate cells, 2𝑚𝑙 of TrypLE™ Express enzyme was added to each T-25 flask
after taking the media out of the flask. TrypLE™ Express enzyme is used instead of
trypsin in harvesting cells because of its lower cell toxicity and higher stability for
more than 12 months at 4℃ and at room temperature. In addition to that,
enzyme assay results proved that at 37℃, TrypLE™ Express enzyme maintains
85% activity for 8 days [17]. After dissociation, six 15𝑚𝑙 tubes were prepared by
labeling them with the cell line name and the media they were seeded in. Cells
were then transferred to the corresponding tube, followed by washing the cells
twice by 3𝑚𝑙 of PBS each time and centrifugation after each wash for 4 minutes
at 200 × 𝑔. Then cells were fixed by adding 1 𝑚𝑙 of 4% paraformaldehyde (PFA)
for 10 minutes in each flask. Cell fixation prevents autolysis and necrosis of
excised tissues and maintains cells morphology and antigenicity during IHC [18].
Cells were then washed with 3𝑚𝑙 of PBS twice and centrifuged after each wash at
400 × 𝑔 for 4 𝑚𝑖𝑛𝑢𝑡𝑒𝑠. In order to block non-specific binding, 3 𝑚𝑙 of blocking
solution (6% goat serum/ 94% PBS) was added for 45 𝑚𝑖𝑛𝑢𝑡𝑒𝑠 to each tube. After
that the primary antibodies CD29/44/105 were added and the cells were
incubated for 1 ℎ𝑜𝑢𝑟 at room temperature. CD29/44/105 are primary mouse
anti-human antibodies that attach to the MSCs gene markers CD29, CD44, and
CD105, respectively. Figure 2 shows more details about these antibodies. The cells
were subsequently washed in 3 𝑚𝑙 of blocking solution twice followed by
centrifugation at 400 × 𝑔 for 4 𝑚𝑖𝑛𝑢𝑡𝑒𝑠 after each wash. Then the secondary
antibody Alexa Fluor® 488 (AF488) was added to the cells for 1 ℎ𝑜𝑢𝑟. Alexa
Fluor® 488 was added at a 1:2000 ratio. Thus, we added 0.25 𝜇𝑙 per 500𝜇𝑙 of
blocking solution per centrifuge tube, followed by washing the cells using 3 𝑚𝑙 of

blocking solution twice and centrifugation after each wash at 400 × 𝑔 for
4 𝑚𝑖𝑛𝑢𝑡𝑒𝑠. AF488 antibody is a green-fluorescent dye that binds to the primary
antibodies CD44/29/105. The cells were permeabilized by adding 3 𝑚𝑙 of
permeabilization solution (50 𝑚𝑙 of high salt buffer with 25 𝜇𝑙 of Tween 20)
thrice and centrifugated after each time at 400 × 𝑔 for 4 𝑚𝑖𝑛𝑢𝑡𝑒𝑠 to allow the
second primary and secondary antibodies enter through the cell membrane.
2.5𝑚𝑙 of the permeabilizing solution was removed followed by adding 0.5𝑚𝑙 of
the second primary antibody, Myosin 11 (MYH 11, 6% goat serum) and incubation
for 1 ℎ𝑜𝑢𝑟 at room temperature. Figure 3 shows more details about MYH11. The
cells were then washed in 3 𝑚𝑙 of blocking solution twice and centrifugated after
each wash at 400 × 𝑔 for 4 𝑚𝑖𝑛𝑢𝑡𝑒𝑠. Subsequently, 2.5𝑚𝑙 of the blocking
solution was removed after washing the cells followed by adding 0.5𝑚𝑙 of the
second secondary antibody CF647 which is a red- fluorescent dye that binds to
the primary antibody MYH11. Then cells were incubated for 1 ℎ𝑜𝑢𝑟 at room
temperature. Finally, the cells were washed in 3 𝑚𝑙 of blocking solution twice and
centrifuged after each wash at 400 × 𝑔 for 4 𝑚𝑖𝑛𝑢𝑡𝑒𝑠. Cells were then stored in
4℃ until FACS was done.

Fluorescence-Activated Cell Sorting (FACS)
2 𝑚𝑙 of the supernatant was removed from each tube to have more concentrated
marker treated cells and the remaining 1 𝑚𝑙 from each tube were transferred
into a glass vial. Then the expression level of MSC and SMC-specific markers were
analyzed using flow cytometer that detects the intracellular and the extracellular
cell markers. This was done using a BDFACSCanto™ II flow cytometer (BD); 20 000

events were collected from each experimental group and the data were analyzed
using FlowJo® software.
A

B

C

Figure 2: Primary antibodies that attach to CD105/44/29 MSCs gene markers (A)Mouse
anti-Hu CD105. (B) Mouse anti-human CD44. (C)Mouse anti-human CD29

Figure 3: Details about the second primary antibody, MYH11 that binds with SMCs
gene marker.

Results
Figure 4 represents the FACS results of ATCC1 cell line that was used as a negative
control to determine the gate. It shows no specific binding because no primary
antibodies were added, only secondary antibody that resulted in the
autofluorescence (background signal). From figure 4a, the gate of the Ad-MSCs
was determined to be 103 because AF488 is the secondary antibody that attaches
to CD105/44/29 which is the primary antibody specific for MSCs gene markers.
Before 103 , there is non-specific binding, so it resulted in negative expression of
AF488 (𝐴𝐹488 − ). After 103 , it showed the specific binding which results in the
positive expression of AF488 (𝐴𝐹488+ ). In other words, 𝐴𝐹488 − means that
particles detected in this region are not mesenchymal stem cells while 𝐴𝐹488+
means that particles detected in this region are mesenchymal stem cells.
Similarly, for figure 4b, the gate of SMCs was determined to be 103 because
CF647 is the secondary antibody that attaches to MYH11 which is the primary
antibody specific for SMCs gene markers.

A

B

Figure 4: FACS results of the ATCC1 cell line, the staining control, after being subjected
to secondary antibodies only showing the gate to be 103 . (A) represents the percentage
of AF488. (B) represents the percentage of MYH11.

Figure 5 represents the percentage of the Ad-MSCs and SMCs of 82726 cell line
after being grown in culture media for 4 days. In Figure 5a, 17% of the events
showed positive expression for CD44 (𝐶𝐷44+ ) which means that 16.9% of the
cells had Ad-MSCs phenotype. On the other hand, in figure 5b, 5.92% of the cells
expressed 𝑀𝑌𝐻11 + which means that these particles had the SMCs phenotype.
A

B

Figure 5: FACS results of 82726 cell line after being seeded in culture media for 4 days.
(A) represents the percentage of Ad-MSCs. (B) represents the percentage of SMCs.

Figure 6 shows the percentage of MSCs and SMCs of 82726 cell line after being
grown for 4 days in the differentiation media 𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1. From figure 6a,
12.8% of the cells expressed 𝐶𝐷44+ which means that they have Ad-MSCs
phenotype. From figure 6b, 6.25% of the particles expressed 𝑀𝑌𝐻11 + which
indicates they have SMCs phenotype.

B

A

Figure 6: FACS results of 82726 cell line after being seeded for 4-day in the media
𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1. (A) represents the percentage of Ad-MSCs. (B) represents the
percentage of SMCs.

Figure 7 represents the percentage of MSCs and SMCs of 99375 cell line after
growing in culture media for 4 days. Figure 7a shows that 2.74% of cells
expressed 𝐶𝐷105+ , so they have the Ad-MSCs phenotype. Figure 7b shows that
7.9% of the particles expressed 𝑀𝑌𝐻11+ , so they have SMCs phenotype.

A

B

Figure 7: FACS results of 99375 cell line after being seeded for 4-days in culture media.
(A) represents the percentage of MSCs. (B) represents the percentage of SMCs.

Figure 8 presents the percentage of MSCs and SMCs of 99375 cell line after being
seeded in 𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1 for 4 days. Figure 8a shows that 1.63% of the particles
expressed 𝐶𝐷105+ , so they have MSCs phenotype. Figure 8b shows that 6.17%
of the particles expressed 𝑀𝑌𝐻11 + , so they have SMCs phenotype.
A

B

Figure 8: FACS results of 99375 cell line after 4-day differentiation in 𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1.
(A) represents the percentage of MSCs. (B) represents the percentage of SMCs.

Discussion
For 82726 cell line, when comparing the results from figures 5b and 6b, it is
concluded that the percentage of SMCs increased when 𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1 was
used and that indicates the differentiation media 𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1 consists of
important growth factors that help in the differentiation of Ad-MSCs derived from
a 24-year old Caucasian female. In addition to that, 4 days is enough for these
growth factors to differentiate this cell line into SMCs.

Regarding cell line 99375, by comparing percentages in figures 7b and 8b, we
conclude that the percentage of SMCs in 𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1 was less than that in
culture media. This indicates the growth factors in the differentiation media
𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1 needs more than 4 days to differentiate cells derived from a 29year old native American female. In other words, the older the donor is, the more
time the cells need to differentiate form Ad-MSCs towards SMCs.

Comparing the percentages of 𝑀𝑌𝐻11+ from figures 6b and 8b, it is concluded
that 82727 cell line expressed more SMCs when cultured in 𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1 than
99375 cell line. This conclusion proves the donor origin has effect on the
differentiation of Ad-MSCs towards SMCs.

Conclusion
Differentiation of Ad-MSCs towards SMCs depends on a lot of external factors:
the origin of the cell, the culture media, age of the donor, passage number, plastic
surface quality, supplementary factors, oxygen concentration, and mechano/electro-stimuli. In addition to the factors, this study proved that the origin of the
donor is considered one of the factors that should be taken into consideration
when generating SMCs form Ad-MSCs. Controlling these factors will result in
increasing the efficiency and productivity of SMCs related clinical applications
such as synthetic vascular graft since SMCs are considered one of its main
components. In the future, triplicates should be done on each cell line (82726,
99375) for each media (culture media, 𝑃𝐷𝐺𝐹 + 𝑇𝐺𝐹𝛽1) to ensure the statistical
significance of the results.
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